ITACONIX PLC (ITX) — Interim Results for the year ended 30 June 2026

Investor webinar replay

Replay transcript excerpt

Good afternoon, and welcome to the ITACONIX PLC twenty twenty six Half Year Results Investor Presentation. Your screen. Simply type in your questions and press send. Before we begin, I would like to submit the following poll. And I would now like to hand you over to CEO, John Shaw. Good afternoon to you, sir. Thank you. We're I look forward to going through our results today and giving you some overview of what we've done and where we end up we'll be going in the near term here. So we started with a very a very good first half, record half year revenues, our fourth half of revenue growth, excellent commercial progress. What's most exciting is we achieved our first half of breakeven EBITDA profitability. We expanded our overall revenues to existing customers. We've landed new important customers, and we achieved that breakeven profitability while still investing in new applications, new products, and key operating improvements. And we ended the half with $5,000,000 to fund continued growth. If you're new to us on on this call or want a quick refresher, we have a very straightforward business and value proposition. Iduconic acid is a natural metabolite found in our bodies and nature, safe and effective. It's produced at industrial scale by fermentation using plant based feedstock from corn. We purchase it on the open market. We bring it into our US operations to react it using our patented processes to produce a broad line of proprietary safer ingredients that improve the performance, affordability, and sustainability of consumer products. We ship our ingredients either directly or through partners around the world to be used in hundreds of consumer products. Generating demand and revenues for our ingredients is also straightforward. Consumer products consumer brands a...